3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Brain Neoplasms
4
Neoplasms
3
Prostatic Neoplasms
2
Urogenital Neoplasms
1
Radiation Pneumonitis
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Optic Neuritis
1
Neoplasm Metastasis
1
Myelitis, Transverse
1
Myelitis
1
Myasthenia Gravis
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
Glioma
1
Genital Neoplasms, Male
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
12
fludarabine phosphate
7
fludarabine
7
venetoclax
6
blinatumomab
6
Cytarabine
5
Lenalidomide
4
Dexamethasone
4
Blood Specimen Collection
4
Azacitidine
4
obinutuzumab
3
Rituximab
3
Radiotherapy
3
Melphalan
3
Immunotherapy, Adoptive
3
pembrolizumab
2
daratumumab
2
Neoadjuvant Therapy
2
Idarubicin
2
Chemotherapy, Adjuvant
2
Capecitabine
2
trastuzumab deruxtecan
1
tislelizumab
1
tisagenlecleucel
1
thymoglobulin
1
tetrathiomolybdate
1
talquetamab
1
tagraxofusp
1
sacituzumab govitecan
1
sabatolimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Adrenal Cortex Hormones
×
1 year
×
Clear all
No trials found.